Open Menu Close Menu
CFO
  • News
  • Resources
  • Webinars
  • CFO Magazine
  • Newsletter
Search

oncology

Illumina Buys Cancer Test Startup Grail for $8B

The deal will move Illumina “deeper into the application of its gene-sequencing technology to the diagnosis and treatment of patients."

Gilead to Buy Cancer Drugmaker for $21 Billion

The acquisition of Immunomedics "represents significant progress in Gilead’s work to build a strong and diverse oncology portfolio."

Roche Buys Flatiron in $1.9B ‘Big Data’ Move

The real-world evidence Flatiron's record system collects "is a key ingredient to accelerate the development of, and access to, new cancer treatments."

CFO
LinkedIn Facebook Twitter YouTube

Stay Updated

Sign up to our weekly newsletter

Email Address:

Topics

  • Accounting & Tax
  • Credit & Capital
  • Risk & Compliance
  • Strategy
  • Technology
  • Human Capital

Content

  • Homepage
  • News
  • Resources
  • Webinars
  • CFO Magazine

About CFO

  • About CFO
  • Privacy Policy
  • Editorial Staff
  • Press
  • Advertise
  • Contact Us

Copyright © 2021 CFO. Industry Dive, Inc. (c) 2021, All rights reserved, 1255 23rd Street, NW, Suite 550, Washington, DC 20037